--- title: "PAVmed (PAVM) news: offering" url: "https://aibio.space/companies/pavmed/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "PAVM offering news: PAVmed reports first quarter 2026 results and simpler capital structure. PAVmed Inc. (NASDAQ: PAVM), United States." --- PAVM PAVmed Inc. NASDAQ · United States # PAVmed (PAVM) news PAVM offering news Company Updates · 2026-08-14 ## [PAVmed reports second quarter 2026 results and Lucid coverage policy](https://aibio.space/news/pavmed-reports-second-quarter-2026-results-lucid-coverage-policy/) Lucid Diagnostics recognized $1.5 million in EsoGuard revenue in the second quarter, and PAVmed reported cash of $3.8 million at June 30, 2026. ## Latest PAVmed news 1. 2026-05-15 Company Updates [PAVmed reports first quarter 2026 results and simpler capital structure](https://aibio.space/news/pavmed-reports-first-quarter-2026-results-simpler-capital-structure/) PAVmed ended the first quarter with $6.5 million in cash, and Lucid Diagnostics' underwritten offering netted about $17 million. ## PAVmed at a glance - **Ticker**: PAVM - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $3.8 million ### Related companies - [Cresco Labs](https://aibio.space/companies/cresco-labs/) OTC: CRLBF - [Picard Medical](https://aibio.space/companies/picard-medical/) NYSE: PMI - [Cadre Holdings](https://aibio.space/companies/cadre/) NYSE: CDRE - [Canopy Growth](https://aibio.space/companies/canopy-growth/) NASDAQ: CGC - [QHSLab](https://aibio.space/companies/qhslab/) OTC: USAQ - [POSITRON CORP](https://aibio.space/companies/positron/) OTC: POSC - [CONMED](https://aibio.space/companies/conmed/) NYSE: CNMD - [HST Global](https://aibio.space/companies/hst-global/) OTC: HSTC ### Also on NASDAQ - [INTEGRA LIFESCIENCES HOLDINGS CORP](https://aibio.space/companies/integra-lifesciences/) IART - [PACIFIC BIOSCIENCES OF CALIFORNIA, INC.](https://aibio.space/companies/pacific-biosciences-of-california/) PACB - [enVVeno Medical](https://aibio.space/companies/envveno-medical/) NVNO - [Ascendis Pharma](https://aibio.space/companies/ascendis-pharma/) ASND - [Corcept Therapeutics](https://aibio.space/companies/corcept-therapeutics/) CORT - [GeoVax Labs](https://aibio.space/companies/geovax-labs/) GOVX ## PAVmed annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | | [$3.0 million](https://www.sec.gov/Archives/edgar/data/1624326/000164117225000364/) | | Research and development | [$4.5 million](https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/) | [$5.9 million](https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/) | | Net income (loss) | [$401,000](https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/) | [$39.8 million](https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/) | | Cash from operations | [-$5.2 million](https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/) | [-$33.6 million](https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/) | | Cash and equivalents | [$1.5 million](https://www.sec.gov/Archives/edgar/data/1624326/000143774926027733/) | [$1.2 million](https://www.sec.gov/Archives/edgar/data/1624326/000143774926010115/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $3.8 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about PAVmed Has PAVmed raised money recently? Our latest story on this, dated May 15, 2026: "PAVmed reports first quarter 2026 results and simpler capital structure". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/pavmed-reports-first-quarter-2026-results-simpler-capital-structure/). What is the ticker symbol of PAVmed? PAVmed Inc. trades under the ticker PAVM on NASDAQ. Where is PAVmed listed? PAVmed Inc. is listed on NASDAQ. Which country or territory is PAVmed listed under? Our directory records PAVmed Inc. under United States. Does aibio.space cover PAVmed? aibio.space lists PAVmed Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Is PAVmed profitable? PAVmed Inc. reported net income of $401,000 for the fiscal year ended Dec 31, 2025, and used $5.2 million of cash in operations, per its annual report to the SEC. How much does PAVmed spend on research and development? $4.5 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does PAVmed have? $3.8 million in cash at Jun 30, 2026, per its 10-Q. What is the latest PAVmed (PAVM) stock news? Our latest story on PAVmed, dated Aug 14, 2026: "PAVmed reports second quarter 2026 results and Lucid coverage policy". Lucid Diagnostics recognized $1.5 million in EsoGuard revenue in the second quarter, and PAVmed reported cash of $3.8 million at June 30, 2026. [Source](https://aibio.space/news/pavmed-reports-second-quarter-2026-results-lucid-coverage-policy/). How can I follow PAVmed (PAVM) news? Press Follow on this page to add PAVmed to your Following list, or subscribe to the aibio.space newsletter. We have published 2 stories naming PAVmed so far, in Company Updates. ## Investor discussion: PAVmed Members talk about PAVmed (PAVM). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at PAVmed, newest first. Each line links the filing it comes from. 1. 2026-10-22 Financings Reported a financing. SEC Form 8-K (Items 1.01,3.03,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1624326/000149315226048138/form8-k.htm) 2. 2026-09-10 Financings Reported a financing. SEC Form 424B5. [Source](https://www.sec.gov/Archives/edgar/data/1624326/000149315226042020/form424b5.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:PAVM on TradingView](https://www.tradingview.com/symbols/NASDAQ-PAVM/). ## Listing details PAVmed Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker PAVM, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: PAVmed Inc. - **Ticker**: PAVM - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/pavmed/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "PAVmed (PAVM) news: offering", 2026-10-31, https://aibio.space/companies/pavmed/